Tolerizing peptide hCDR1 induces lupus-like symptom in mice

Yushi SUN,Fei YANG,Lingyu BAO,Yue WANG,Fengyi ZHAO,Xiang JIAO,Jing YANG,Bingyin SHI
DOI: https://doi.org/10.13753/j.issn.1007-6611.2017.03.008
2017-01-01
Abstract:Objective To explore the possibility of hCDR1,a peptide based on the complementarity determining region (CDR) 1 of a human monoclonal anti-DNA autoantibody,inducing an SLE-like disease in B6D2F1 mice.Methods Forty B6D2F1 mice were divided into five groups randomly:hCDR1 20 μg group,100 μg group,500 μg group,normal control group and positive control group[chronic graft versus host disease murine model of lupus (SLE-cGVHD)].Mice were subcutaneously injected with 0.2 ml hCDR1 in hCDR1 groups and 0.2 ml adjuvant in normal control group.SLE-cGVHD was induced by intravenous injections of parental female DBA/2 lymphocytes.The serum hCDR1 antibody,anti-dsDNA antibody,anti-histone antibody and total IgG were detected by ELISA.Kidney specimens were observed by immunofluorescence and histological examination.Results SLE-like symptoms were successfully induced by hCDR1 in 100 μg group and 500 μg group.Compared with normal control group,mice in 100 μg group and 500 μg group acquired higher OD value of dsDNA antibodies (P < 0.05) and anti-histone antibodies (P < 0.05).Compared with normal control group,peripheral blood PLT significantly decreased,while peripheral blood WBC increased in 100 μg group and 500 μg group(P < 0.05).In 100 μg group and 500 μg group,75% mice got nephritis characterized by proteinuria and immunocomplex deposition in glomeruli.No SLE-like symptom was detected in 20 μg hCDR1 immunized mice and normal control mice.Conclusion SLE-like symptom could be induced by hCDR1 in B6D2F1 mice.
What problem does this paper attempt to address?